| Monograph Title
|
Monograph Section
|
Scientific Liaison
|
| TAZOBACTAM PF 34(2) Pg. 302 | Identification | Ahalya Wise |
| TAZOBACTAM PF 34(2) Pg. 302 | Specific rotation <781S> | Ahalya Wise |
| TAZOBACTAM PF 34(2) Pg. 302 | Related compounds | Ahalya Wise |
| TAZOBACTAM PF 34(2) Pg. 302 | Organic volatile impurities, Method IV <467> | Ahalya Wise |
| TAZOBACTAM PF 34(2) Pg. 302 | Assay | Ahalya Wise |
| TIAGABINE HYDROCHLORIDE PF 34(2) Pg. 306 | Chromatographic purity | Ravi Ravichandran |
| TOBRAMYCIN INHALATION SOLUTION PF 34(2) Pg. 307 | Identification | Ahalya Wise |
| TOBRAMYCIN INHALATION SOLUTION PF 34(2) Pg. 307 | OsmolarityOsmolality and Osmolarity <785> | Ahalya Wise |
| TOBRAMYCIN INHALATION SOLUTION PF 34(2) Pg. 307 | Chromatographic purityRelated compounds | Ahalya Wise |
| TOBRAMYCIN INHALATION SOLUTION PF 34(2) Pg. 307 | Other requirements | Ahalya Wise |
| TOBRAMYCIN INHALATION SOLUTION PF 34(2) Pg. 307 | Assay | Ahalya Wise |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Title | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Chemical Info | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Definition | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Packaging and storage | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | USP Reference standards <11> | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Identification | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Specific rotation <781S> | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Water, Method Ic <921> | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Residue on ignition <281> | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Related compounds | Sujatha Ramakrishna |
| TRANDOLAPRIL PF 34(2) Pg. 310 | Assay | Sujatha Ramakrishna |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | Title | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | Definition | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | Packaging and storage | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | USP Reference standards | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | Identification | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | pH | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | Limit of travoprost related compound A | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | Limit of degradation products | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 31(4) Pg. 1121 | Assay | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 32(4) Pg. 1118 | Definition | Feiwen Mao |
| TRAVOPROST OPHTHALMIC SOLUTION PF 32(4) Pg. 1118 | Limit of travoprost related compound A | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Title | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Chemical structure | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Chemical formula | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Molecular weight | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Chemical names | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | CAS number | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Definition | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Packaging and storage | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | USP Reference standards | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Identification A, B | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Water | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Specific rotation | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Related compounds | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Limit of ethyl acetate | Feiwen Mao |
| TRAVOPROST PF 31(4) Pg. 1119 | Assay | Feiwen Mao |
| TRAVOPROST PF 32(4) Pg. 1115 | Definition | Feiwen Mao |
| TRAVOPROST PF 32(4) Pg. 1115 | Identification | Feiwen Mao |
| TRAVOPROST PF 32(4) Pg. 1115 | Limit of ethyl acetate | Feiwen Mao |
| TRAVOPROST PF 32(4) Pg. 1115 | Related compounds | Feiwen Mao |
| TRIAMTERENE CAPSULES PF 34(3) Pg. 654 | USP Reference standards <11> | Sujatha Ramakrishna |
| TRIAMTERENE CAPSULES PF 34(3) Pg. 654 | Related compounds | Sujatha Ramakrishna |
| TRIAMTERENE CAPSULES PF 34(3) Pg. 654 | Assay | Sujatha Ramakrishna |
| ZIDOVUDINE CAPSULES PF 34(3) Pg. 657 | Related compounds | Behnam Davani |
| ZIDOVUDINE CAPSULES PF 34(3) Pg. 657 | Assay | Behnam Davani |
| ZIDOVUDINE INJECTION PF 34(3) Pg. 658 | Related compounds | Behnam Davani |
| ZIDOVUDINE INJECTION PF 34(3) Pg. 658 | Assay | Behnam Davani |
| ZIDOVUDINE PF 34(3) Pg. 656 | Assay | Behnam Davani |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Title | Curtis Phinney |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Definition | Curtis Phinney |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Packaging and storage | Curtis Phinney |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Labeling | Curtis Phinney |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Identification | Curtis Phinney |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Microbial enumeration <2021> | Radha Tirumalai |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Absence of specified microorganisms <2022> | Radha Tirumalai |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Disintegration and dissolution <2040> | Natalia Davydova |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Weight variation <2091> | Curtis Phinney |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Assay for zinc | Curtis Phinney |
| ZINC AND VITAMIN C LOZENGES PF 34(2) Pg. 317 | Assay for Vitamin C | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Title | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Chemical Info | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Definition | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Packaging and storage | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Identification | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Microbial enumeration <2021> | Radha Tirumalai |
| ZINC CITRATE PF 34(2) Pg. 315 | Absence of specified microorganisms <2022> | Radha Tirumalai |
| ZINC CITRATE PF 34(2) Pg. 315 | Loss on drying | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Chloride <221> | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Sulfate <221> | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Limit of arsenic, cadmium, and lead | Curtis Phinney |
| ZINC CITRATE PF 34(2) Pg. 315 | Assay | Curtis Phinney |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Title | Curtis Phinney |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Definition | Curtis Phinney |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Packaging and storage | Curtis Phinney |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Labeling | Curtis Phinney |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Identification | Curtis Phinney |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Microbial enumeration <2021> | Radha Tirumalai |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Absence of specified microorganisms <2022> | Radha Tirumalai |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Disintegration and dissolution <2040> | Natalia Davydova |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Weight variation <2091> | Curtis Phinney |
| ZINC CITRATE TABLETS PF 34(2) Pg. 316 | Assay | Curtis Phinney |
